Clinical Trial Update: Dotarem vs Gadobutrol Contrast for Breast MRI [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Dotarem (gadoterate meglumine) with Gadobutrol for breast MRI has completed; results are not detailed in this summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Diseases

Drugs mentioned

• DOTAREM (Gadoterate meglumine)
• Gadavist (gadobutrol)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Breast Diseases | Phase 4 | Status: COMPLETED